| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.29B | -1.7% |
| Cost of Revenue | $1.23B | -9.1% |
| Gross Profit | $1.06B | +8.6% |
| R&D Expense | $227.3M | +34.6% |
| SG&A Expense | $137.8M | -1.5% |
| Operating Income | $445.7M | -0.6% |
| Interest Expense | $8.8M | -6.3% |
| Pre-tax Income | $513.1M | +13.5% |
| Income Tax | $74.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.7M | -39.0% |
| Short-term Investments | $1.41B | +23.4% |
| Accounts Receivable | $446.0M | +1.1% |
| Inventory | $213.6M | +42.7% |
| Current Assets | $2.44B | +7.9% |
| Total Assets | $3.38B | +9.7% |
| Current Liabilities | $532.4M | -16.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $696.8M | -6.4% |
| Capital Expenditures | $110.4M | +137.7% |
| Investing Cash Flow | -$366.4M | +1.5% |
| Financing Cash Flow | -$516.8M | -2917.5% |
| Free Cash Flow | $586.4M | -16.0% |
| +35.7% |
| Net Income | $438.9M | +10.5% |
| Long-term Debt |
| $1.29B |
| +0.3% |
| Total Liabilities | $2.40B | +6.2% |
| Stockholders' Equity | $983.6M | +19.1% |